SANDHYA PRASHAD: Open Payments
NPI 1821237991 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,139 in 59 payments from 11 companies in 2025. Trend: 2023 $17,099 · 2024 $4,810 · 2025 $2,139
Food & beverage: $2,123Education: $16
| Company | Payments | Amount |
|---|---|---|
| Brainsway USA INC | 1 | $1,174 |
| Bausch Health US, LLC | 16 | $196 |
| Otsuka America Pharmaceutical, Inc. | 9 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $136 |
| ABBVIE INC. | 5 | $102 |
| Lundbeck LLC | 3 | $63 |
| Noven Therapeutics, LLC | 3 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: deep tms, REXULTI, APLENZIN, TRINTELLIX, CAPLYTA, VRAYLAR, Xelstrym, SPRAVATO.
Industry payments across TX — which companies pay providers there.
